In the current study, we have generated iFGFR1-expressing DCIS.COM cell lines and used these cell lines as a model to study the impact of FGFR1 signaling on the growth, progression and gene expression of breast DCIS tumor cells. The gene discussed is FGFR1; the disease is ductal breast carcinoma in situ.